Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Dissecting novel virulent determinants in the Burkholderia cepacia complex.

Tegos GP, Haynes MK, Schweizer HP.

Virulence. 2012 May 1;3(3):234-7. doi: 10.4161/viru.19844. Epub 2012 May 1.

2.

A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence.

Thomson EL, Dennis JJ.

Virulence. 2012 May 1;3(3):286-98. doi: 10.4161/viru.19355. Epub 2012 May 1.

3.

[Advances in virulence determinants in Burkholderia cepacia complex--a review].

Tang Q, Zhu H, Qin W.

Wei Sheng Wu Xue Bao. 2014 May 4;54(5):487-97. Review. Chinese.

PMID:
25199247
4.

Common duckweed (Lemna minor) is a versatile high-throughput infection model for the Burkholderia cepacia complex and other pathogenic bacteria.

Thomson EL, Dennis JJ.

PLoS One. 2013 Nov 6;8(11):e80102. doi: 10.1371/journal.pone.0080102. eCollection 2013.

5.

Exposing the third chromosome of Burkholderia cepacia complex strains as a virulence plasmid.

Agnoli K, Schwager S, Uehlinger S, Vergunst A, Viteri DF, Nguyen DT, Sokol PA, Carlier A, Eberl L.

Mol Microbiol. 2012 Jan;83(2):362-78. doi: 10.1111/j.1365-2958.2011.07937.x. Epub 2011 Dec 16.

6.

Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex.

Seed KD, Dennis JJ.

Infect Immun. 2008 Mar;76(3):1267-75. doi: 10.1128/IAI.01249-07. Epub 2008 Jan 14.

7.

The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans.

Sousa SA, Ramos CG, Moreira LM, Leitão JH.

Microbiology. 2010 Mar;156(Pt 3):896-908. doi: 10.1099/mic.0.035139-0. Epub 2009 Nov 26.

PMID:
19942656
8.

Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts.

Uehlinger S, Schwager S, Bernier SP, Riedel K, Nguyen DT, Sokol PA, Eberl L.

Infect Immun. 2009 Sep;77(9):4102-10. doi: 10.1128/IAI.00398-09. Epub 2009 Jun 15.

9.

The multifarious, multireplicon Burkholderia cepacia complex.

Mahenthiralingam E, Urban TA, Goldberg JB.

Nat Rev Microbiol. 2005 Feb;3(2):144-56. Review.

PMID:
15643431
10.

Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species.

Leitão JH, Sousa SA, Ferreira AS, Ramos CG, Silva IN, Moreira LM.

Appl Microbiol Biotechnol. 2010 Jun;87(1):31-40. doi: 10.1007/s00253-010-2528-0. Review.

PMID:
20390415
11.

The Burkholderia cenocepacia K56-2 pleiotropic regulator Pbr, is required for stress resistance and virulence.

Ramos CG, Sousa SA, Grilo AM, Eberl L, Leitão JH.

Microb Pathog. 2010 May;48(5):168-77. doi: 10.1016/j.micpath.2010.02.006. Epub 2010 Mar 3.

PMID:
20206249
12.

Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice.

Sousa SA, Ulrich M, Bragonzi A, Burke M, Worlitzsch D, Leitão JH, Meisner C, Eberl L, Sá-Correia I, Döring G.

Cell Microbiol. 2007 Dec;9(12):2817-25. Epub 2007 Jul 11.

PMID:
17627623
13.

Burkholderia multivorans survival and trafficking within macrophages.

Schmerk CL, Valvano MA.

J Med Microbiol. 2013 Feb;62(Pt 2):173-84. doi: 10.1099/jmm.0.051243-0. Epub 2012 Oct 25.

PMID:
23105020
14.

Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence.

Silva IN, Ferreira AS, Becker JD, Zlosnik JE, Speert DP, He J, Mil-Homens D, Moreira LM.

Microbiology. 2011 Nov;157(Pt 11):3124-37. doi: 10.1099/mic.0.050989-0. Epub 2011 Aug 11.

PMID:
21835880
15.

The Use of Synthetic Hybrid Strains to Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.

Agnoli K, Freitag R, Gomes MC, Jenul C, Suppiger A, Mannweiler O, Frauenknecht C, Janser D, Vergunst AC, Eberl L.

Appl Environ Microbiol. 2017 Apr 21. pii: AEM.00461-17. doi: 10.1128/AEM.00461-17. [Epub ahead of print]

PMID:
28432094
16.

A decade of Burkholderia cenocepacia virulence determinant research.

Loutet SA, Valvano MA.

Infect Immun. 2010 Oct;78(10):4088-100. doi: 10.1128/IAI.00212-10. Epub 2010 Jul 19. Review.

17.

Phase variation has a role in Burkholderia ambifaria niche adaptation.

Vial L, Groleau MC, Lamarche MG, Filion G, Castonguay-Vanier J, Dekimpe V, Daigle F, Charette SJ, Déziel E.

ISME J. 2010 Jan;4(1):49-60. doi: 10.1038/ismej.2009.95. Epub 2009 Aug 27.

PMID:
19710710
18.

Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.

Mahenthiralingam E, Baldwin A, Dowson CG.

J Appl Microbiol. 2008 Jun;104(6):1539-51. doi: 10.1111/j.1365-2672.2007.03706.x. Epub 2008 Jan 24. Review.

19.

Update on the Burkholderia cepacia complex.

Lipuma JJ.

Curr Opin Pulm Med. 2005 Nov;11(6):528-33. Review.

PMID:
16217180
20.

Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.

Seed KD, Dennis JJ.

Antimicrob Agents Chemother. 2009 May;53(5):2205-8. doi: 10.1128/AAC.01166-08. Epub 2009 Feb 17.

Supplemental Content

Support Center